COVID-19 research in Stockholm and Hong Kong is focus of webinar
KTH and its strategic partner university, Hong Kong University of Science and Technology, are hosting a webinar, Thursday, Dec. 3, to discuss each of the institutions' recent discoveries and breakthroughs on COVID-19.
KTH Biochemistry Professor Per Berglung is the academic coordinator for the KTH-HKUST strategic partnership. He'll deliver the opening remarks when
This is the second coronavirus-related joint webinar with HKUST, right?
PB: Yes, we held our first webinar in June to examine how people respond to the pandemic from perspectives such as social and cultural, public health, public transportation, and urban planning and design. Scientists from both universities were presenting their research on that. So, this time the perspective is life science.
What can viewers expect to gain from tuning in tomorrow?
PB: They will learn about fascinating world-leading research and also see important examples of how universities are facing the challenge of solving the coronavirus problem.
Will viewers be able to ask questions?
PB: A questions and answers session will follow the four short talks. Viewers can post questions during the entire time through the chat function.
What if I miss the presentation, will it be archived?
PB: Yes, it will be recorded and will be available afterwards to watch.
Tell us a little about the partnership between HKUST and KTH - why are the two universities presenting together on this topic?
PB: HKUST is one of about six key university partners to KTH around the globe. The partnership with HKUST has existed for many years and there are, for instance, joint research projects sponsored from both sides. COVID-19 is a timely topic and much is happening scientifically so in this second seminar, it felt natural to focus on other research areas, such as the life-science area which also has a strong research reputation at both universities.
What is the possibility of more joint KTH/HKUST webinars going forward? Do you have anything in the works?
PB: We are at both sides planning to continue on a regular basis, though nothing has been decided yet regarding topic.
David Callahan
